Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Non-interventional, Registry Study of Patients Initiating a Course of DrugTherapy for Overactive Bladder (OAB)

NCT02386072 is registered in ClinicalTrials.gov with Astellas Scientific & Medical Affairs, Inc. as lead sponsor.

NCT NCT02386072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02386072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Non-interventional, Registry Study of Patients Initiating a Course of DrugTherapy for Overactive Bladder (OAB)
Lead sponsor
Astellas Scientific & Medical Affairs, Inc.
Phase
Observational
Overall status
Completed
Start date
January 5, 2015
Completion date
August 4, 2017
Enrollment
1,524 (actual)
Sites
92

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, urinary bladder diseases, urinary bladder overactive, urologic diseases